Elicio Therapeutics (ELTX) Interest & Investment Income (2022 - 2026)
Elicio Therapeutics posted quarterly Interest & Investment Income of $157000.0 for Q1 2026, down 25.24% year-on-year from $210000.0 in Q1 2025, and down 21.11% on a QoQ basis from $199000.0 in Q3 2025.
Elicio Therapeutics (ELTX) has 5 years of Interest & Investment Income data on file, last reported at $157000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 25.24% year-over-year to $157000.0; the trailing twelve-month figure through Mar 2026 stood at $734000.0 (up 7.62% YoY), and the FY2023 full-year result was $373000.0, up 473.85% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $157000.0, down from $199000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $246000.0 in Q3 2023 and bottomed at $10000.0 in Q3 2022.
- The 5-year median for Interest & Investment Income is $150000.0 (2024), against an average of $126230.8.
- The widest annual swing landed in 2023, when Interest & Investment Income jumped 2360.0%; it then fell 25.24% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $55000.0 in 2022, then jumped by 36.36% to $75000.0 in 2023, then jumped by 146.67% to $185000.0 in 2024, then advanced by 7.57% to $199000.0 in 2025, then dropped by 21.11% to $157000.0 in 2026.
- The last three Interest & Investment Income figures came in at $157000.0 (Q1 2026), $199000.0 (Q3 2025), and $168000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 210,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 137,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 246,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 10,000.00 |